human
metapneumoviru
hmpv
human
respiratori
syncyti
viru
hrsv
ubiquit
respiratori
viral
pathogen
belong
famili
paramyxovirida
subfamili
pneumovirina
respons
acut
respiratori
tract
infect
children
elderli
immunocompromis
patient
design
test
multiplex
revers
transcriptas
polymeras
chain
reaction
mrtpcr
costeffect
altern
realtim
pcr
cell
cultur
base
detect
hmpv
hrsv
newli
develop
pcr
use
screen
nasalthroat
swab
sampl
patient
suspect
acut
respiratori
infect
attend
govern
medic
colleg
thiruvananthapuram
kerala
india
method
compar
commerci
avail
kit
employ
real
time
pcr
sensit
specif
sampl
posit
least
one
test
pathogen
mrtpcr
except
one
among
posit
sampl
show
similar
pathogen
profil
test
use
real
time
pcr
among
posit
hrsva
posit
hrsvb
posit
hmpv
sampl
show
coinfect
sensit
specif
mrtpcr
compar
commerci
kit
find
indic
newli
develop
mrtpcr
use
costeffect
altern
laboratori
diagnosi
hmpvhrsv
infect
significantli
reduc
diagnost
cost
virus
clinic
set
keyword
acut
respiratori
infect
human
metapneumoviru
human
respiratori
syncyti
viru
multiplex
revers
transcriptas
pcr
realtim
revers
transcriptas
pcr
electron
supplementari
materi
onlin
version
articl
global
acut
respiratori
infect
ari
report
account
approxim
total
death
children
year
age
human
respiratori
syncyti
viru
hrsv
human
metapneumovirus
hmpv
neg
sens
singlestrand
rna
virus
main
caus
agent
ari
human
worldwid
across
age
group
real
challeng
treat
infect
accur
low
cost
earli
diagnosi
suitabl
use
resourc
poor
set
http
wwwjhsphedu
real
time
revers
transcriptas
polymeras
chain
reaction
rrtpcr
replac
less
sensit
time
consum
techniqu
like
viral
cultur
serolog
diagnosi
viral
respiratori
diseas
adult
howev
cost
test
sometim
hinder
accur
clinic
diagnosi
due
ever
increas
number
respiratori
virus
repertoir
caus
clinic
indistinguish
diseas
phenotyp
current
diagnosi
human
respiratori
syncyti
viru
hrsv
human
metapneumoviru
hmpv
reli
molecular
detect
viral
rna
use
rrtpcr
overlap
clinic
symptom
also
seen
coinfect
thu
develop
multiplex
revers
transcriptas
polymeras
chain
reaction
mrtpcr
assay
detect
hmpvhrsv
clinic
specimen
costeffect
altern
compar
efficaci
establish
rrtpcr
found
newli
develop
mrtpcr
great
potenti
use
epidemiolog
vigil
clinic
diagnosi
compar
specif
sensit
rrtpcr
primari
object
present
studi
analyz
acut
respiratori
tract
infect
children
year
age
adult
year
age
sampl
collect
june
novemb
patient
south
india
nasalthroat
swab
collect
clinic
suspect
ari
anorexia
bronchiol
cough
diarrhea
diffus
wheez
rale
dyspnea
fever
hoars
myalgia
rhiniti
sore
throat
sputum
copd
vomit
subject
govern
medic
colleg
thiruvananthapuram
kerala
india
inform
consent
prior
enrol
patient
sampl
gentli
rub
nasal
turbinatethroat
caviti
moisten
cotton
tip
swab
place
ml
hivir
transport
kit
himedia
laboratori
india
specimen
transport
laboratori
cold
store
process
rrtpcr
mrtpcr
assay
hmpv
hrsv
perform
freezethaw
aliquot
total
nucleic
acid
rrtpcr
analysi
isol
nasalthroat
swab
sampl
use
recommend
spinstar
nucleic
acid
kit
adt
biotech
malaysia
accord
manufactur
recommend
viscou
sampl
pretreat
kit
provid
mucolyt
agent
prior
extract
qiaamp
viral
rna
mini
kit
use
extract
total
rna
mrtpcr
analysi
sampl
also
test
gapdh
mrtpcr
assay
check
adequ
recoveri
sampl
rna
absenc
rtpcr
inhibitor
primer
mrtpcr
supplementari
design
consensu
genom
region
obtain
gen
bank
http
wwwncbinlmnihgov
viru
procur
sigma
aldrich
bangalor
india
primer
hrsva
b
design
evolutionarili
conserv
nucleoprotein
gene
hmpv
matrix
gene
lg
rna
templat
use
pcr
reaction
use
super
script
iii
onestep
rtpcr
system
reaction
also
contain
rsva
forward
lm
rsva
revers
lm
rsvb
forward
lm
rsvb
revers
lm
hmpv
forward
lm
hmpv
revers
lm
primer
reaction
mix
superscript
iii
rtplatinum
taq
mix
invitrogen
life
technolog
final
volum
neg
water
posit
rrtpcr
confirm
patient
sampl
control
run
experi
pcr
reaction
perform
use
follow
reaction
condit
gene
amp
pcr
system
appli
biosystem
usa
first
min
min
inactiv
revers
transcriptas
follow
pcr
amplif
initi
denatur
step
cycl
denatur
anneal
extens
min
follow
final
extens
step
min
amplifi
product
electrophores
agaros
gel
stain
ethidium
bromid
solut
visual
use
syngen
gbox
syngen
usa
gel
document
system
fig
rrtpcr
assay
singl
tube
detect
hrsva
hrsvb
done
use
realstar
rsv
rtpcr
kit
altona
diagnost
gmbh
germani
realstar
hmpv
rtpcr
kit
altona
diagnost
gmbh
germani
use
detect
hmpv
clinic
sampl
twenti
microlit
extract
eluent
use
templat
pcr
amplif
rrtpcr
fig
agaros
gel
analysi
pcr
product
mrtpcr
hrsv
hmpv
clinic
sampl
two
posit
clinic
sampl
use
control
test
primer
specif
assay
follow
manufactur
instruct
use
rotor
gene
realtim
platform
qiagen
germani
fig
b
repres
pcr
product
mrtpcr
confirm
use
sanger
sequenc
use
forward
primer
use
pcr
revers
primer
use
case
forward
primer
reaction
fail
sequenc
protocol
agaros
gel
purifi
fresh
pcr
product
subject
cycl
sequenc
use
big
dye
termin
cycl
sequenc
kit
appli
biosystem
usa
accord
manufactur
instruct
sequenc
read
use
abi
prism
sequenc
appli
biosystem
usa
result
analyz
use
sequenc
analysi
softwar
appli
biosystem
usa
obtain
sequenc
subject
ncbi
blast
analysi
http
blastncbi
nlmnihgov
sequenc
homolog
analysi
sequenc
obtain
current
studi
subject
align
repres
global
sequenc
report
studi
construct
phylogenet
tree
check
strain
related
use
molecular
evolutionari
genet
analysi
mega
softwar
statist
analysi
carri
use
epitool
epitool
epidemiolog
calcul
ausvet
anim
health
servic
http
epitoolsausvetcomau
agreement
two
test
determin
use
concord
kappa
agreement
concord
kappa
coeffici
measur
agreement
two
variabl
provid
robust
measur
simpl
percent
agreement
sensit
specif
one
test
refer
vice
versa
also
calcul
analyt
sensit
multiplex
assay
determin
test
serial
dilut
quantifi
rna
target
experi
repeat
five
time
check
consist
diagnosi
viru
clinic
manifest
record
time
sampl
collect
supplementari
indistinct
hrsv
hmpv
associ
ill
sampl
posit
least
one
test
pathogen
among
subject
test
mrtpcr
tabl
sampl
also
posit
detect
pathogen
mrtpcr
test
use
rrtpcr
except
one
detect
mrtpcr
tabl
overal
concord
method
kappa
correl
concord
kappa
coeffici
detect
individu
viral
pathogen
compar
rrtpcr
follow
hrsva
hrsv
b
hmpv
respect
tabl
sensit
specif
mrtpcr
overal
respect
individu
pathogen
hrsva
hrsvb
hmpv
respect
rrtpcr
detect
consid
gold
standard
tabl
hand
sensit
specif
rrtpcr
respect
mrtpcr
taken
gold
standard
individu
pathogen
show
follow
sensit
specif
respect
hrsva
hrsvb
hmpv
tabl
blast
data
confirm
amplifi
product
hrsv
hmpv
repres
hrsva
sequenc
cluster
close
strain
india
access
china
access
usa
access
minimum
ident
wherea
hrsvb
sequenc
cluster
vietnam
isol
access
ident
hmpv
sequenc
cluster
isol
singapor
access
ident
fig
major
respiratori
viral
pathogen
record
global
influenza
viru
rhino
viru
corona
viru
human
respiratori
viru
metapneumoviru
studi
attempt
rapid
diagnosi
respiratori
virus
use
multiplex
pcr
use
molecular
test
diagnosi
import
respiratori
viral
caus
agent
hrsvhmpv
gain
wide
accept
diagnosi
hmpv
even
tougher
viru
difficult
isol
cell
cultur
consid
necess
rapid
diagnosi
clinician
viru
isol
cell
cultur
replac
molecular
diagnost
test
rrtpcr
method
reliabl
diagnosi
hmpv
respiratori
secret
current
test
choic
studi
develop
evalu
multiplex
pcr
assay
aim
provid
tool
capabl
detect
complet
panel
known
respiratori
virus
hmpv
infect
act
enhanc
chronic
obstruct
pulmonari
diseas
concurr
patient
copd
prone
hmpv
infect
studi
date
also
shown
signific
correl
hrsv
infect
develop
childhood
asthma
children
experienc
rsv
bronchiol
first
decad
life
oppos
older
children
clinic
data
studi
also
probabl
point
fact
famili
histori
asthma
could
signific
nonmodifi
risk
factor
hrsv
infect
supplementari
addit
recent
studi
report
rsv
rna
identifi
patient
chronic
obstruct
pulmonari
diseas
period
exacerb
asymptomat
period
similar
rate
thu
warrant
develop
costeffect
rapid
test
like
mrtpcr
screen
asymptomat
carrier
vulner
popul
outbreak
scenario
supplementari
best
knowledg
first
studi
southern
india
employ
singl
step
mrtpcr
detect
hmpv
hrsv
directli
clinic
sampl
confirm
hmpvhrsv
etiolog
method
give
prompt
respons
h
import
therapi
critic
avoid
unwant
use
antibiot
mrtpcr
nasopharyng
aspir
swab
consid
reliabl
method
establish
diagnosi
hmpvhrsv
infect
clinic
sampl
multiplex
platform
allow
concurr
detect
sever
respiratori
virus
advantag
provid
specif
result
rapid
turnaround
time
becom
increasingli
viabl
commerci
use
viral
coinfect
describ
previous
infect
patient
differ
studi
mrt
pcr
method
also
detect
signific
proport
sampl
coinfect
virus
posit
sampl
concord
method
hrsv
hmpv
rsv
b
contradictori
report
associ
hrsv
hmpv
coinfect
diseas
sever
studi
found
coinfect
lead
increas
rate
intens
care
unit
admitt
other
found
associ
coinfect
diseas
sever
howev
patient
popul
primarili
year
children
year
adult
therefor
larger
studi
chronic
ill
elderli
patient
need
conclus
may
gener
patient
subgroup
mrtpcr
assay
may
econom
due
fact
multipl
pathogen
detect
singl
assay
without
proport
increas
reagent
cost
drawback
well
detect
sensit
often
lower
equival
monoplex
pcr
assay
thu
care
design
mrtpcr
detect
sensit
compar
monoplex
assay
produc
reproduc
result
nevertheless
isol
viral
caus
agent
remain
gold
standard
basic
model
studi
genet
antigen
chang
viru
popul
well
mean
detect
new
respiratori
virus
mrtpcr
score
monoplex
rrtpcr
limit
resourc
set
overal
cost
reduct
may
justifi
routin
use
rapid
molecular
diagnost
assay
compar
rrtpcr
assay
actual
perform
least
threefold
lesser
cost
without
compromis
qualiti
importantli
real
time
pcr
machin
expens
compar
convent
pcr
